
Utilization — not cost growth — continues to accelerate spending, government actuaries said. Spiking prescription drug spending, including on GLP-1s, is e
specially acute.
https://www.hrdive.com/news/us-health-spending-spikes-57t-2025/823718/

Utilization — not cost growth — continues to accelerate spending, government actuaries said. Spiking prescription drug spending, including on GLP-1s, is e
specially acute.
https://www.hrdive.com/news/us-health-spending-spikes-57t-2025/823718/